The estimated Net Worth of Michael I Schaffer is at least $945 mil dollars as of 16 December 2022. Michael Schaffer owns over 100 units of Psychemedics stock worth over $84,632 and over the last 21 years he sold PMD stock worth over $510,793. In addition, he makes $349,800 as Vice President - Laboratory Operations at Psychemedics.
Sign up
Michael Schaffer PMD stock SEC Form 4 insiders trading
Michael has made over 11 trades of the Psychemedics stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 100 units of PMD stock worth $495 on 16 December 2022.
The largest trade he's ever made was exercising 16,600 units of Psychemedics stock on 10 March 2014 worth over $239,040. On average, Michael trades about 928 units every 53 days since 2004. As of 16 December 2022 he still owns at least 37,201 units of Psychemedics stock.
You can see the complete history of Michael Schaffer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael Schaffer biography
Dr. Michael I. Schaffer Ph.D. serves as Vice President - Laboratory Operations of the Company. He has served as Vice President of Laboratory Operations since 1999. Since December 2016, he has served as a member of the Drug Testing Advisory Board (DTAB) which advises the administrator of Substance Abuse and Mental Health Services Administration (SAMHSA) on drug testing activities and laboratory certification. From 1990 to 1999, he served as Director of Toxicology, Technical Manager and Responsible Person for the Leesburg, Florida laboratory of SmithKline Beecham Clinical Laboratories. From 1990 to 1999, he was also a member of the Board of Directors of the American Board of Forensic Toxicologists. Dr. Schaffer has also served as an inspector for the College of American Pathologists since 1990.
What is the salary of Michael Schaffer?
As the Vice President - Laboratory Operations of Psychemedics, the total compensation of Michael Schaffer at Psychemedics is $349,800. There are 3 executives at Psychemedics getting paid more, with Raymond Kubacki having the highest compensation of $736,800.
How old is Michael Schaffer?
Michael Schaffer is 75, he's been the Vice President - Laboratory Operations of Psychemedics since 1999. There are 4 older and 5 younger executives at Psychemedics. The oldest executive at Psychemedics Corp. is Harry Connick, 94, who is the Independent Director.
What's Michael Schaffer's mailing address?
Michael's mailing address filed with the SEC is C/O PSYCHEMEDICS CORPORATION, 289 GREAT ROAD, SUITE 200, ACTON, MA, 01720.
Insiders trading at Psychemedics
Over the last 21 years, insiders at Psychemedics have traded over $2,633,903 worth of Psychemedics stock and bought 95,845 units worth $742,060 . The most active insiders traders include Peter Kamin, A Clinton Allen y Raymond C Jr Kubacki. On average, Psychemedics executives and independent directors trade stock every 101 days with the average trade being worth of $18,935. The most recent stock trade was executed by Charles M Doucot on 17 August 2023, trading 12,700 units of PMD stock currently worth $59,182.
What does Psychemedics do?
psychemedics (nasdaq: pmd) is the world's leading drug testing company using hair for the detection of drugs of abuse. psychemedics has been successfully operating for 30 years and thousands of corporations worldwide currently rely on psychemedics’ patented hair analysis technology for their pre-employment and employee drug screening. psychemedics' clients include over 10% of the fortune 500, some of the largest police departments in america, federal reserve banks, and schools. for more information, visit the psychemedics website at www.psychemedics.com.
What does Psychemedics's logo look like?
Complete history of Michael Schaffer stock trades at Psychemedics
Psychemedics executives and stock owners
Psychemedics executives and other stock owners filed with the SEC include:
-
Raymond Kubacki,
Chairman of the Board, President, Chief Executive Officer -
Raymond C. Kubacki,
Chairman, CEO & Pres -
Charles Doucot,
Executive Vice President -
Michael Schaffer,
Vice President - Laboratory Operations -
Charles M. Doucot IV,
Exec. VP -
Dr. Michael I. Schaffer Ph.D.,
VP of Laboratory Operations -
A. Clinton Allen,
Independent Director -
Fred Weinert,
Independent Director -
Walter Tomenson,
Independent Director -
Harry Connick,
Independent Director -
Patrick J. Kinney Jr.,
Sec. -
Sarah Ashby,
VP & Gen. Counsel -
Andrew Limbek,
VP of Fin. & Controller -
Annette Baumgartner,
Founder -
Dr. Werner A. Baumgartner Ph.D.,
Founder -
Peter Kamin,
Director -
Neil Lerner,
VP - Finance -
James V. Dyke,
Vice President - Sales -
Michael Weisenhoff,
-
Raymond J Ruddy,
Vice President/Controller -
Jonathan D Compton,
Vice President - Marketing -
William R Thistle,
Sr. VP and Gen. Counsel -
Peter C Monson,
VP, Treas., CFO & Asst. Sec. -
Jennifer Chmieleski,
Vice President, Controller -
Richard T Christoph,
10% owner -
William Dausey,
Vice President of Sales -
Robyn C Davis,
Director -
Andrew Reynolds,
Director -
Shannon Shoemaker,
Chief Revenue Officer -
Darius G Nevin,
Director -
Brian Hullinger,
President & CEO -
Daniella Mehalik,
Vice President - Finance